1. Phase II cardiotoxicity study of mitoxantrone hydrochloride using exercise radionuclide evaluation of the left ventricular cardiac ejection fraction (LVEF);Aapro,1982
2. Phase I clinical trial of mitoxantrone: a new anthracenedione anticancer drug;Alberts;Cancer Chemother. Pharmacol.,1980
3. Phase II trial of dihydroxyanthracenedione in acute leukemia;Estey,1982
4. Pharmacokinetic studies of dihydroxyanthracenedione (DHAD, NSC 301,739) with clinical correlations;Neidhart,1981
5. A randomized study of mitoxantrone (M) and adriamycin (A) in breast cancer patients failing primary therapy;Neidhart,1982